Compositions and methods for localized drug delivery through mammary papillae
The invention provides compositions and methods for the prevention, diagnosis, or treatment of conditions affecting breast tissue. The compositions can include one or more therapeutic agents or diagnostic agents, and an effective carrier. The composition can be specifically adapted for transdermal permeation through the mammary papilla, areola, or a combination thereof, and into underlying breast tissue.
1. A composition for the treatment of a condition affecting breast tissue comprising an alcoholic component, a therapeutic agent, and an effective carrier, the composition being adapted for transdermal permeation through the mammary papilla, areola, or a combination thereof, and into underlying breast tissue, wherein said carrier is an extract of sandalwood oil wherein said extract comprises α-santalol, and wherein said therapeutic agent is selected from 5-fluorouracil, cyclophosphamide, tamoxifen, adriamycin, danazol, progesterone, doxorubicin, paclitaxel, cisplatin, or docetaxel.
2. The composition of claim 1 , wherein the composition is a microemulsion.
3. The composition of claim 1 , wherein the composition is a hydroalcoholic solution.
4. The composition of claim 1 , wherein the composition comprises at least 5% α-santalol (v/v).
5. The composition of claim 1 , wherein the composition comprises between about 5% to about 25% α-santalol (v/v).
6. A composition comprising α-santalol, an alcohol, optionally a surfactant, and a compound selected from the group consisting of 5-fluorouracil, cyclophosphamide, tamoxifen, adriamycin, danazol, progesterone, doxorubicin, paclitaxel, cisplatin, docetaxel, nitrosoureas, camptothecins, lipophilic statins, retinoids, and daunomycin.
7. A method of treating a subject with breast cancer comprising: (a) applying sufficient alcohol to the outer surface of mammary papillae tissue of the subject to remove the keratin plug therein; and (b) administering the composition of claim 6 to the alcohol treated mammary papillae at a sufficient does to produce a therapeutic effect.
8. The method of claim 7 , wherein said surface is dry prior to the administering step.
9. The method of claim 7 , wherein the composition comprises α-santalol, an alcohol, a surfactant and tamoxifen in the form of a microemulsion.
10. The method of claim 7 , wherein the composition comprises between about 5% to about 25% α-santalol (v/v).